TABLE 1.
Summary of the characteristics related to the infection and treatment
| Average | (Number of patients) percent | |
|---|---|---|
| Severity classification | ||
| Mild | (3) 7.3% | |
| Moderate | (17) 41.5% | |
| Severe | (16) 39% | |
| Critical | (5) 12.2% | |
| Stay in ICU | ||
| Yes | (31) 75.6% | |
| No | (10) 24.4% | |
| Intubation | ||
| Yes | (5) 12.2% | |
| No | (36) 87.8% | |
| Negative PCR Result | ||
| ≤9 d | (16) 39% | |
| Between 9 and 14 d | (8) 19.5% | |
| Between 14 and 30 d | (15) 36.6% | |
| >30 d | (2) 4.9% | |
| C‐reactive protein CRP | ||
| Normal | (15) 36.6% | |
| High | (26) 63.4% | |
| White blood cells | ||
| Normal | (23) 56.1% | |
| High | (18) 43.9% | |
| Lymphopenia | ||
| No | (30) 73.2% | |
| Yes | (11) 26.8% | |
| TSQM II treatment satisfaction score | ||
| Effectiveness | 66.29% ± 19.99 | |
| Side effects | 78.54% ± 24.71 | |
| Convenience | 70.68% ± 15.69 | |
| Global satisfaction | 70.27 ± 13.49 | |
Abbreviations: CRP, C‐reactive protein; ICU, intensive care unit; PCR, polymerase chain reaction; TQCM, treatment satisfaction questionnaire for medication.